|
- Fig.1. Evolution of the combined pain– mobility
score (CPMS) for the three treatment groups during the
study (mean value + 1 SD).
- Table 3. Mean change in BMD as a percentage of the
baseline value after 3 years for three groups.
Treatment
group
Mann-Whitney U-Test
|
|
A (n = 31) |
B (n = 30) |
C (n = 33) |
ANOVA |
A/B |
A/C |
B/C |
|
L2-4 |
12.59+9.59 |
19.48+18.53 |
-1.64=2.86 |
P <0.001 |
P =0.0363 |
P =0.0000 |
P =0.0000 |
|
Femur, neck |
2.33+6.51 |
-1.80+5.52 |
-6.25+1.78 |
P <0.001 |
P =0.007 |
P =0.0000 |
P =0.0000 |
|
Femur, Ward’s triangle |
7.50+9.69 |
8.65+10.54 |
-2.25+1.88 |
P <0.001 |
P =0.7400 |
P =0.0000 |
P =0.0000 |
|
Femur, trochanter |
3.49+7.57 |
2.11+7.29 |
-4.40+2.08 |
P <0.001 |
P =0.5639 |
P =0.0000 |
P =0.0000 |
|
Radius 1/3 |
2.32+5.12 |
-1.45+5.44 |
-5.82+2.70 |
P <0.001 |
P =0.0033 |
P =0.0000 |
P =0.0000 |
|
Radius 1/10 |
10.38+13.31 |
13.87+13.85 |
-1.92+3.82 |
P <0.001 |
P =0.1661 |
P =0.0000 |
P =0.0000 |
|
These statement on
mericon-industries.com have not been evaluated by the Food and Drug
Administration. The
products and research on this website are not intended to diagnose, treat or cure or prevent disease.
Mericon Industries, Inc
All Rights Reserved 1998-20 10 |
|
